WHAT'S UP IN

Enzyme inhibitor

Are CDK4/6 Inhibitors Transforming Breast Cancer Treatment?

By:The Tutu Team | 6th April 2017

Source: Breast Cancer Research Foundation Science News CDK4/6 inhibitors are a new class of drugs...

By:The Tutu Team | 23rd March 2017

Author: Ines Martins / Source: Breast Cancer News Adding the CDK4/6 inhibitor...

By:The Tutu Team | 11th October 2016

The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improves...

By:The Tutu Team | 11th October 2016

The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improved...

By:The Tutu Team | 25th June 2016

Background: ErbB2-positive breast cancer is characterized by highly aggressive phenotypes and...